
Ezekiel Weis
Sessions in which Ezekiel Weis participates
Thursday 9 June, 2022
Friday 10 June, 2022
Learning Objectives:At the end of this session participants will be able to:• Integrate new research techniques and ideas in managing Oculoplastics conditions. CanMeds Roles: Medical Expert, Collaborator
Sessions in which Ezekiel Weis attends
Thursday 15 June, 2023
Admission to this session is included in the full registration fee. If you wish to attend this session as a stand-alone event only, please contact Rita Afeltra at rafeltra@cos-sco.ca to register.
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Recognize orbital imaging findings of ocular conditions and surgeriesDescribe the various medical management options for Thyroid Eye DiseaseManage infections of...
Learning Objectives: At the end of this session, participants will be able to: Integrate novel research ideas into clinical practice Describe key research outcomes in oculoplastics CanMEDS Roles: Scholar, Medical ExpertX
Learning Objectives: At the end of this session, participants will be able to: Integrate oncological principles in the management of oculoplastics disordersCanMEDS Roles: Medical Expert, Professional
Thursday 19 June, 2025
Additional authors: Ezekiel Weis, Guy Negretti, Mandeep Sagoo
Additional authors: Andrzej Kulaga, Ezekiel Weis, Kris Langdon, Alex Ragan Fiona Costello
Friday 20 June, 2025
Author’s Name(s): Kimberly Papp, Samuel Baugh, Ezekiel Weis, Robert Goldberg, Kelsey RoelofsAuthor’s Disclosure Block: Kimberly Papp, none; Samuel Baugh, none; Ezekiel Weis, none; Robert Goldberg, none; Kelsey Roelofs, Dr. Roelofs is a consultant for Amgen.Abstract BodyPurpose: To investigate the rate of transformation of eyelid lentigo maligna (LM) to invasive melanoma and to assess the impact of surgical management on dise...
Saturday 21 June, 2025
Learning Objectives: At the end of this session, participants will be able to:Describe recent advances in the diagnosis and treatment of intraocular and extraocular ophthalmic tumors, tailored to the needs of general ophthalmologists and ocular oncologists.